The statements below are read from NIDAN LABS AND HEALTH LTD’s filed results, 4 filed quarters and 8 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed Jul 18, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H1 FY25Sep 2024 | H2 FY25Mar 2025 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|---|
| Sales | 10.5 | 14.0 | 13.1 | 12.4 | -11.2% |
| 7.94 | 11.5 | 10.6 | 10.1 | -12.2% | |
| Operating profit | 2.60 | 2.46 | 2.54 | 2.30 | -6.6% |
| OPM % | 24.7% | 17.6% | 19.4% | 18.5% | +0.9 pp |
| Other income | 1.03 | 1.22 | 1.17 | 0.69 | -43.7% |
| Interest | 0.88 | 1.26 | 0.88 | 1.07 | -15.3% |
| Depreciation | 1.34 | 1.07 | 0.92 | 0.98 | -9.1% |
| Profit before tax | 1.41 | 1.35 | 1.90 | 0.54 | -59.9% |
| Tax % | 22.1% | 35.0% | 24.7% | 86.6% | +51.7 pp |
| Net profit | 1.10 | 0.88 | 1.43 | 0.07 | -91.8% |
| EPS (₹) | 0.79 | 0.63 | 1.03 | 0.05 | -92.1% |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
